Document is current
Any future updates will be listed below
-
Authors
Brunner, Hanna L. https://orcid.org/0000-0002-3446-3738
Kalis, Robert W. https://orcid.org/0000-0001-7553-4806
Grundmann, Lorenz https://orcid.org/0000-0002-0365-5913
Hodáková, Zuzana https://orcid.org/0000-0002-2599-0333
Koskova, Zuzana https://orcid.org/0000-0002-6817-7721
Grishkovskaya, Irina https://orcid.org/0000-0003-0164-9373
de Almeida, Melanie
Hinterndorfer, Matthias https://orcid.org/0000-0003-2435-4690
Knaudt, Hannah https://orcid.org/0009-0005-0772-9042
Höfflin, Simon
Andersch, Florian https://orcid.org/0000-0001-6847-3355
Kotisch, Harald
Dickmanns, Achim
Cuylen-Haering, Sara https://orcid.org/0000-0002-1193-4648
Zuber, Johannes https://orcid.org/0000-0001-8810-6835
Haselbach, David https://orcid.org/0000-0002-5276-5633
- License Information
-
More Information
Article History
Received: 11 March 2025
Accepted: 27 January 2026
First Online: 4 February 2026
Competing interests
: J.Z. is a founder, shareholder and scientific advisor of Quantro Therapeutics. J.Z., D.H. and the Zuber and Haselbach laboratories receive research support and funding from Boehringer Ingelheim. The remaining authors declare no competing interests.
